Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
Springer Nature raises 2026 revenue forecast after strong half-year growth
Springer Nature reported currency-adjusted revenue growth of 6% to €940m for H1 2026 and an adjusted operating profit increase of 8% to €246m; the adjusted operating margin improved by 38 basis points. Free cash flow rose to €268m and net leverage fell to 1.6x. The research segment remains the growth driver with around 80% of revenue; Open Access and higher article publications drove the growth. Management raised the full-year outlook for currency-adjusted revenue growth to about 6% and cites AI initiatives as a strategic focus; the shares rose about 2.9%. » Altro su de.investing.com
Springer Nature raises full-year outlook after strong first half
Springer Nature has raised its forecast: organic revenue growth is now expected to be around 6% (previously 5–6%), and the operating margin is forecast to improve by at least 0.3 percentage points. In the first half, group revenue rose 1.5% to €939.8m (organic 6.2%) and adjusted operating income increased to €246.2m. Analysts highlighted the stronger numbers, the share price rose sharply, while net profit fell to €101.3m, in part due to higher taxes and currency effects. » Altro su finanzen.net
Springer Nature pays dividend of 0.83 EUR for 2025 and rises sharply
At the annual general meeting, Springer Nature approved a dividend of 0.83 EUR per share for fiscal year 2025 (total payout 25.90 million EUR), an increase of 538.46% from the previous year. The dividend yield for 2025 is 4.34% and the stock traded ex-dividend; FactSet expects an increase to 0.84 EUR for 2026 (yield 4.45%). Other key figures: market capitalization 3.998 billion EUR, P/E ratio 10.69, revenue 2025: 1.926 billion EUR, EPS 1.79 EUR. » Altro su finanzen.net
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 939.80m | 1,50% |
| Utile lordo | 375.20m | 0,95% |
| Utile netto | 101.30m | 21,72% |
| EBITDA | 340.20m | 30,16% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 4.02b€ |
Numero di azioni | 198.89m |
Massimo/minimo a 52 settimane | 23,50€ - 14,82€ |
Rendimento da dividendo | 4,19% |
Dividendi TTM | 0,83€ |
Beta | -0,09 |
Rapporto P/E | 8,15 |
Rapporto PEG | 0,04 |
Rapporto P/B | 2,01 |
Rapporto P/S | 1,38 |
Profilo aziendale
| Nome | Springer Nature |
| CEO | Franciscus Vrancken Peeters |
| Quotazione in borsa | 02/10/2024 |
| Dipendenti | 9.400 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
XETRA | SPG.DE |
Frankfurt | SPG.F |
Düsseldorf | SPG.DU |
Hamburg | SPG.HM |
München | SPG.MU |
Scopri gli asset
Gli azionisti di Springer Nature investono anche nei seguenti asset